Azacitidine Injection, Powder, Lyophilized, For Solution
Product Images NDC 68001-527

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Azacitidine (NDC 68001-527). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Azacitidine For Inj Carton)

Carton (Azacitidine For Inj Carton)
This is a description of Azacitidine, a medication that comes in a blue box with a file name 51 1966 0 729146-Azacitidine Inj-100mg-Box. It is intended for subcutaneous and intravenous use, and caution is advised as it is a cytotoxic agent. The medication comes in a single-dose vial containing 100mg of azacitidine and 100mg of mannitol in lyophilized powder form which must be diluted before use. Detailed prescribing information should be consulted for administration and dosage instructions. Vials should be stored between 15° to 30°C, and unused portions should be discarded. The label also includes information about the manufacturer's details and Mfg. Lic. No. The product has dimensions of 145mm in length, 45mm in width, and 75mm in height.*
FDA Label Image

Label (Azacitidine For Inj Label)

Label (Azacitidine For Inj Label)
This is a description of a medication called Azacitidine. It comes in a single-use vial that contains 100mg of Azacitidine and 100mg of mannitol. The prescribing information should be consulted for the proper dosage and administration. The medication is for injection and any unused portion should be discarded. The medication must be stored at a temperature between 15°C to 30°C (59°F to 86°F). It is manufactured by Intas Pharmaceuticals Limited, located in Ahmedabad, India. This medication is a cytotoxic agent and should only be used under the direction and supervision of a healthcare professional.*
FDA Label Image

Kaplan-meier Curve Of Time To Death From Any Cause: (intent-to-treat Population) (Azacitidine For Inj Plot)

Kaplan-meier Curve Of Time To Death From Any Cause:  (intent-to-treat Population) (Azacitidine For Inj Plot)
This is a survival analysis of two treatments (AZA and CCR) for an unspecified medical condition. The Log-Rank p-value indicates that there is a statistically significant difference in survival between the two treatments, with AZA being associated with better survival outcomes. The Hazard Ratio (HR) is also reported, with 95% confidence interval. The graph shows the proportion of patients surviving over time, with time measured in months. The number of patients at risk at each time point is also displayed.*
FDA Label Image

Azacitidine Structural Formula (Azacitidine For Inj Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.